Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Hepatitis B
2
Química clínica
2
Aspectos moleculares
1
Carcinogénesis química
1
Cáncer
1
Difteria
1
Enfermedades transmisibles
1
Epidemiología
1
Español
1
Hepatitis
1
Hepatitis A.
1
Hepatitis B.
1
Hepatitis C
1
Influenza
1
Inglés
1
Modelos matemáticos
1
Prevención y control
1
Tetanos
1
Tos Ferina
1
Tétanos
1
-
15461por Ou, Xi, Guan, Jing, Chen, Jing-Sen, Ying, Jie-Cao, Liu, Xiao-Ping, Tian, Pei-Kai, Liu, Ji-Kui, Nie, Li-Ping, Zhao, Yang, Yu, Guang-Yin“…Flow cytometric analysis was performed to detect the proportion of LAP(+)CD4(+) T cells among the peripheral blood mononuclear cells (PBMCs) of 30 HBV-infected HCC patients at the pre-operative and post-operative stages, as well as 30 hepatitis B virus (HBV)-infected volunteers as a control group. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15462“…CHD1L expression was associated with gallstone history, serum carbohydrate antigen 19-9 (CA19-9) level and Tumor-Node-Metastasis (TNM) stage (P<0.05). hMLH1 expression in cholangiocarcinoma (77.78%) was significantly lower than in normal bile duct tissues (96.67%), and was associated with gender, age, serum CA19-9 level, the presence of hepatitis B virus surface antigen, TNM stage and tumor diameter (P<0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15463por Pane, M., Sianturi, E. I., Kong, Yin Mei Fiona, Bautista, Philip, Herlina, Taxis, K.“…Being 31 to 40 years old (odds ratio (OR) = 0.55, 95% confidence interval (CI) = 0.32–0.93, > 40 years (OR = 0.30, 95% CI = 0.16–0.55) vs < 30 years, hepatitis B/C co-infection (OR = 0.42, 95% CI = 0.24–0.75), living > 20 km from the hospital (OR = 0.55, 95% CI = 0.33–0.93), transmission male-to-male (OR = 0.13, 95% CI = 0.04–0.44), unemployment (OR = 1.88, 95% CI = 1.02–3.44), part-time employment (OR = 10.71, 95% CI = 4.09–28.02), household member with HIV (OR = 3.31, 95% CI = 1.70–6.44), and Christianity (OR = 1.82, 95% CI = 1.12–2.94) were associated with regular counselling attendance. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15464por Jiang, Weixi, Huang, Sirun, Teng, Hua, Wang, Peipei, Wu, Meng, Zhou, Xia, Ran, Haitao“…PARTICIPANTS: Patients with NAFLD who had a liver stiffness measurement using pSWE and TE before liver biopsy were enrolled according to the following criteria: 2×2 contingency tables can be calculated via the reported number of cases; sensitivity and specificity were excluded according to the following criteria: history of other hepatic damage, such as chronic hepatitis C, concurrent active hepatitis B infection, autoimmune hepatitis, suspicious drug usage and alcohol abuse. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15465por Li, Yarui, Guo, Dan, Zhao, Yan, Ren, Mudan, Lu, Guifang, Wang, Yun, Zhang, Juan, Mi, Chen, He, Shuixiang, Lu, Xinlan“…The quantitative real-time PCR results showed that SNHG5 was up-regulated in both HCC tissues and hepatoma cell lines and was closely associated with tumor size, hepatitis B virus infection, histologic grade, TNM stage, and portal vein tumor thrombus (PVTT) in HCC patients. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15466por Lin, Kyawzaw, Lin, Aung Naing, Linn, Sandar, Hlaing, Pwint Phyu, Vasudevan, Viswanath, Reddy, Madhavi“…Viral serology for acute hepatitis B, C, E, cytomegalovirus, Epstein-Barr virus, and varicella zoster virus was negative. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15467por Tufon, Kukwah Anthony, Anong, Damian Nota, Meriki, Henry Dilonga, Georges, Teuwafeu Denis, Maurice, Mouladje, Kouanou, Youmbi Sylvain, Bolimo, Ayah Flora, Tony, Nyeke James, Kwenti, Tebit Emmanuel, Wung, Ndze Henry, Nkuo-Akenji, Theresa“…BACKGROUND: The management of patients with chronic hepatitis B infection is quite complex because it requires an in-depth knowledge of the natural history of the disease. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15468por Blok, Joris J., Putter, Hein, Metselaar, Herold J., Porte, Robert J., Gonella, Federica, de Jonge, Jeroen, van den Berg, Aad P., van der Zande, Josephine, de Boer, Jacob D., van Hoek, Bart, Braat, Andries E.“…RESULTS: Recipient age, model for end-stage liver disease sodium, ventilatory support, diabetes mellitus, hepatocellular carcinoma, previous malignancy, hepatitis C virus antibody, hepatitis B virus antibody, perfusion fluid, and Eurotransplant donor risk index (ET-DRI) had significant impact on outcome (graft or patient survival) at 1 or multiple points in time. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15469por Flores, Yvonne N, Zhang, Zuo-Feng, Bastani, Roshan, Leng, Mei, Crespi, Catherine M, Ramírez-Palacios, Paula, Stevens, Heather, Salmerón, Jorge“…The following known risk factors for liver disease/cancer were evaluated: elevated aminotransferase levels (elevated alanine aminotransferase was defined as > 40 IU/L for males and females; elevated aspartate aminotransferase was defined as > 40 IU/L for males and females), infection with hepatitis B or hepatitis C, metabolic syndrome, high total cholesterol, diabetes, obesity, abdominal obesity, and heavy alcohol use. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15470por Zhu, Zhenfeng, Xu, Litao, Zhuang, Liping, Ning, Zhouyu, Zhang, Chenyue, Yan, Xia, Lin, Junhua, Shen, Yehua, Wang, Peng, Meng, Zhiqiang“…RESULTS: The optimal cut-off point for MLR was 0.35, and MLR level had no significant correlation with age, gender, hepatitis B infection, grade, alpha-fetoprotein (AFP) level and state of portal vein tumor thrombus. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15471por Palafox, Neal A., Reichhardt, Martina, Taitano, John Ray, Nitta, Mavis, Garstang, Helentina, Riklon, Sheldon, Taulung, Livinson, Buenconsejo-Lum, Lee E.“…Cancer risk factors such as obesity, tobacco, and Hepatitis B are prevalent. Twelve years of nuclear testing in the RMI adds to the cancer burden. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15472por Diaz, Heidi Torres, Serrano, Ruth, Bowling, Jason E, Anstead, Gregory, Javeri, Heta“…Eleven patients had Hepatitis C (HCV) and one had active Hepatitis B infection. Ten patients had MTB pulmonary infection, thee had latent TB infection, two meningitis, and three had disseminated disease. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15473por Weller, Melodie, Cooke, Elaine, GhaziTabatabaei, Amir, Yeh, Chih-Ching, Zhang, Yue“…BACKGROUND: A significant increase in the yearly incidence of hepatitis delta virus (HDV) diagnosis in hepatitis B virus (HBV) patient populations has been identified through analysis of global infectious disease datasets. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15474“…Exclusion criteria included patients who received ART for hepatitis B infection or prophylaxis, HIV post-exposure prophylaxis, or patients receiving a first dose of ART for occupational exposure. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15475“…The demographics of UCSD patients are as follows: Age range of 23–100 (median 45), 71% male (median age 47) and 29% female (median age 39). Concurrent hepatitis B (in 5.5%) and hepatitis C (in 18.5%) were present. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15476“…We designed, implemented, and started to evauate an intervention to initiate MAT in conjuction with the managament of the infectious diseases complications and a standardized approach to screening these patients for HIV, hepatitis B/C and offering PrEP, HIV therapy, and/or HCV therapy where appropriate. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15477“…Results: Epi-HAML showed significant differences compared to HCC group in terms of clinical features such as sex preference, age, concomitant diseases (hepatitis B and cirrhosis), and elevated plasma alpha-fetoprotein (AFP) (P < 0.001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15478“…The healthy control group (AUC, 0.926; sensitivity, 0.87% and specificity, 0.82%) demonstrated high diagnostic capacity of miR-21-5p compared with the chronic hepatitis B infection group (AUC, 0.904; sensitivity, 0.75% and specificity, 0.84%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15479por Weng, Li-Chueh, Huang, Hsiu-Li, Lee, Wei-Chen, Tsai, Yu-Hsia, Lin, Ching-Rong, Wang, Woan-Shyuan, Wang, Yi-Wen, Yang, Tsui-Yun, Tseng, Li-Chuan“…The withdrawal group had fewer recipients with an hepatitis B virus infection than did the other groups (χ(2) = 9.28, P = .01). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15480por Wang, Changzheng, Pang, Shujie, Si-Ma, Hui, Yang, Ning, Zhang, Haibin, Fu, Yong, Yang, Guangshun“…Cox’s proportional hazards regression model showed that microvascular invasion (HR = 2.084, 95% CI 1.115–3.897, P = 0.021), multiple tumors (HR = 2.071, 95% CI 1.185–3.616, P = 0.010), abnormal elevation of serum CA19-9 (HR = 1.619, 95% CI 1.076–2.437, P = 0.021), and the negative hepatitis B status (HR = 1.650, 95% CI 1.123–2.427, P = 0.011) were independent risk factors for early recurrence, and HBV-DNA level > 10(6) IU/mL (HR = 1.785, 95% CI 1.015–3.141, P = 0.044) and a hepatolithiasis history (HR = 2.538, 95% CI 1.165–5.533, P = 0.010) contributed to late recurrence independently. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto